Research Article

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors

Figure 1

(a) Activity value versus DPLL. (b) Activity value versus H. (c) Activity value versus HF. (d) Activity value versus HOMO. (e) Activity value versus MR. (f) Activity value versus Pc. (g) Activity value versus TIndx. (h) Activity value versus VP. (i) Activity value versus WIndx.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)